Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia

References

• Initiative ST, World Health Organization. The Stop TB Partnership Annual Report 2006: A Portrait of Progress. Geneva: World Health Organization; 2007.
   Google Scholar
• Sharma S, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121(4):550–567.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report; 2012.
   Google Scholar
• Unaids A. by the numbers; 2016. 2017.
   Google Scholar
• Wang H, Wolock TM, Carter A, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3(8):e361–e387. doi:10.1016/S2352-3018(16)30087-X
   PubMed Web of Science ®Google Scholar
• Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J. 2009;33(4):871–881. doi:10.1183/09031936.00168008
   PubMed Web of Science ®Google Scholar
• Deribew A, Tesfaye M, Hailmichael Y, et al. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes. 2009;7(1):105. doi:10.1186/1477-7525-7-105
   Web of Science ®Google Scholar
• Organization WH. Global tuberculosis control: surveillance, planning, financing: WHO report 2008. Vol 393. World Health Organization; 2008.
   Google Scholar
• Demissie M, Lindtjørn B, Tegbaru B. Human Immunodeficiency virus (HIV) infection in tuberculosis patients in Addis Ababa. Ethiopian J Health Develop. 2000;14(3). doi:10.4314/ejhd.v14i3.9900
   Google Scholar
• Ahmed Yassin M, Takele L, Gebresenbet S, et al. HIV and tuberculosis coinfection in the southern region of Ethiopia: a prospective epidemiological study. Scand J Infect Dis. 2004;36(9):670–673. doi:10.1080/00365540410020848
   PubMedGoogle Scholar
• Adams M, Luguterah A. Longitudinal analysis of change in CD4+ cell counts of HIV-1 patients on antiretroviral therapy (ART) in the Builsa district hospital. Eur Scientific J. 2013;9(33).
   Google Scholar
• Aabye MG, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One. 2009;4(1):e4220. doi:10.1371/journal.pone.0004220
   Web of Science ®Google Scholar
• Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med. 1993;148(5):1292–1297.
   PubMed Web of Science ®Google Scholar
• Fujiwara P, Clevenbergh P, Dlodlo R. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis [State of the Art Series. HIV infection in low-income, high-burden settings, Edited by JF Murray. Number 5 in the series]. Int J Tuberculosis Lung Dis. 2005;9(9):946–958.
   Web of Science ®Google Scholar
• Dessie ZG, Zewotir T, Mwambi H, North D. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model. BMC Infect Dis. 2020;20:1–14. doi:10.1186/s12879-020-04972-1
   Web of Science ®Google Scholar
• Temesgen A, Kebede T. Joint modeling of longitudinal CD4 count and weight measurements of HIV/tuberculosis co-infected patients at Jimma University specialized hospital. Ann Data Sci. 2016;3(3):321–338. doi:10.1007/s40745-016-0085-9
   Google Scholar
• Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis. 2006;33(3):143–148. doi:10.1097/01.olq.0000187262.56820.c0
   PubMed Web of Science ®Google Scholar
• Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731–747. doi:10.1007/s10461-008-9489-7
   PubMed Web of Science ®Google Scholar
• Manyara J. Factors associated with delayed antiretroviral therapy initiation among Tuberculosis/Human Immunodeficiency Virus co-infected patients in Lupane district, 2015; 2016.
   Google Scholar
• Bello EJM, Correia AF, Marins JRP, Merchan-Hamann E, Kanzaki LIB. Predictors of virologic failure in HIV/AIDS patients treated with highly active antiretroviral therapy in Brasília, Brazil during 2002–2008. Drug Target Insights. 2011;5(DTI):S7527. doi:10.4137/DTI.S7527
   Google Scholar
• Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. JAIDS. 2004;35(3):261–268. doi:10.1097/00126334-200403010-00006
   Web of Science ®Google Scholar
• Katubulushi M, Zulu I, Yavwa F, Kelly P. Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia. Aids. 2005;19(1):102–103. doi:10.1097/00002030-200501030-00016
   Web of Science ®Google Scholar
• Katlama C, Esposito R, Gatell JM, et al. Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1. Aids. 2007;21(4):395–402. doi:10.1097/QAD.0b013e328013d9d7
   PubMed Web of Science ®Google Scholar
• Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. JAIDS. 2011;58(1):32–37. doi:10.1097/QAI.0b013e3182255dc2
   Web of Science ®Google Scholar
• Montales MT, Chaudhury A, Beebe A, Patil S, Patil N. HIV-associated TB syndemic: a growing clinical challenge worldwide. Fron Public Health. 2015;3:281. doi:10.3389/fpubh.2015.00281
   Google Scholar
• Silva DI, Braga Ceccato M, Rosa Silveira M, et al. Predictors of mortality among individuals with tuberculosis and human immunodeficiency virus coinfection at a reference center in southeastern Brazil: a Retrospective Cohort Study. J Young Pharmacists. 2018;10(4):476–480. doi:10.5530/jyp.2018.10.103
   Web of Science ®Google Scholar